1. Gene therapy in urologic oncology

   • Jeffrey R. Gingrich
   • Mitchell S. Steiner

   EDITORIAL Pages: 91 - 92

2. Transcriptionally regulated adenoviruses for prostate-specific gene therapy

   • Yi Lu
   • Mitchell S. Steiner

   Pages: 93 - 101

3. Osteocalcin-directed gene therapy for prostate-cancer bone metastasis

   • Kenneth S. Koeneman
   • Chinghai Kao
   • Thomas A. Gardner

   Pages: 102 - 110

4. Adenovirus p16 gene therapy for prostate cancer

   • James A. Allay
   • Mitchell S. Steiner
   • Yi Lu

   Pages: 111 - 120

5. Ad5CMVp53 gene therapy for locally advanced prostate cancer – where do we stand?

   • Paul Sweeney
   • Louis L. Pisters

   Pages: 121 - 124

6. Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene

   • Moshe Shalev
   • Brian J. Miles
   • Dov Kadmon

   Pages: 125 - 129

7. Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer

   • Waleed Hassan
   • Michael A. Sanford
   • Simon J. Hall

   Pages: 130 - 135

8. Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development

   • Linda G. Charles
   • Yilin C. Xie
   • Martin G. Sanda

   Pages: 136 - 142

9. Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directions

   • Allan J. Pantuck
   • Amnon Zisman
   • Arie S. Belldegrun

   Pages: 143 - 147

10. Gene therapy for bladder cancer

    • Lance C. Pagliaro

    Pages: 148 - 151

11. Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex

    • David M. J. Hoffman
    • Robert A. Figlin

    Pages: 152 - 156

12. B7-1 gene-modified autologous tumor-cell vaccines for renal-cell carcinoma

    • Scott J. Antonia
    • John D. Seigne

    Pages: 157 - 163